Living therapeutics of nonpathogenic bacteria as biosynthesis factory and active carriers for enhancing tumor-targeted therapy
Abstract Anaerobic bacteria-mediated tumor therapy faces multiple challenges, including potential toxic side effects, complex manufacturing processes, and impaired hypoxic targeting. Here, based on the excellent biocompatibility and distinctive metabolic ability of natural anaerobic sulfate-reducing...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-07-01
|
| Series: | Nature Communications |
| Online Access: | https://doi.org/10.1038/s41467-025-61675-4 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849331889583685632 |
|---|---|
| author | Mengna Dong Xinhui Yang Wenqian Zhang Yuzhi Qiu Peng Song Hongfang Liu Yajiang Yang Xiangliang Yang Qin Wang |
| author_facet | Mengna Dong Xinhui Yang Wenqian Zhang Yuzhi Qiu Peng Song Hongfang Liu Yajiang Yang Xiangliang Yang Qin Wang |
| author_sort | Mengna Dong |
| collection | DOAJ |
| description | Abstract Anaerobic bacteria-mediated tumor therapy faces multiple challenges, including potential toxic side effects, complex manufacturing processes, and impaired hypoxic targeting. Here, based on the excellent biocompatibility and distinctive metabolic ability of natural anaerobic sulfate-reducing bacteria (SRB) to dissimilate sulfate into sulfide, we construct in situ-biosynthesized ferrous sulfide nanoparticle-SRB (FeS@SRB) biohybrid to enhance tumor-targeted therapy. Interestingly, SRB acts as both a biosynthesis factory and active tumor-targeted delivery vehicles. Our systematic studies reveal that FeS@SRB has excellent biosafety and tumor targeting capabilities, achieving over 50% tumor delivery efficiency in female mice post-intravenous injection, which is 17 times higher than that of conventional chemically-synthesized FeS@BSA nanoparticles. Upon near-infrared laser irradiation, FeS@SRB hybrids exhibit synergistic photothermal-chemodynamic effect, amplifying oxidative stress to trigger tumor cells ferroptosis and apoptosis, thereby effectively suppressing both subcutaneous and orthotopic tumor growth. This SRB-based therapeutic strategy expands research into tumor-targeting platforms and the biosynthesis of metal sulfide nanoparticles for enhanced tumor therapy. |
| format | Article |
| id | doaj-art-5807108bf23f4158a2ab20b7e4b257bf |
| institution | Kabale University |
| issn | 2041-1723 |
| language | English |
| publishDate | 2025-07-01 |
| publisher | Nature Portfolio |
| record_format | Article |
| series | Nature Communications |
| spelling | doaj-art-5807108bf23f4158a2ab20b7e4b257bf2025-08-20T03:46:23ZengNature PortfolioNature Communications2041-17232025-07-0116112110.1038/s41467-025-61675-4Living therapeutics of nonpathogenic bacteria as biosynthesis factory and active carriers for enhancing tumor-targeted therapyMengna Dong0Xinhui Yang1Wenqian Zhang2Yuzhi Qiu3Peng Song4Hongfang Liu5Yajiang Yang6Xiangliang Yang7Qin Wang8Hubei Key Laboratory of Bioinorganic Chemistry and Materia Medica, Hubei Engineering Research Center for Biomaterials and Medical Protective Materials, School of Chemistry and Chemical Engineering, Huazhong University of Science and TechnologyHubei Key Laboratory of Bioinorganic Chemistry and Materia Medica, Hubei Engineering Research Center for Biomaterials and Medical Protective Materials, School of Chemistry and Chemical Engineering, Huazhong University of Science and TechnologyHubei Key Laboratory of Bioinorganic Chemistry and Materia Medica, Hubei Engineering Research Center for Biomaterials and Medical Protective Materials, School of Chemistry and Chemical Engineering, Huazhong University of Science and TechnologyHubei Key Laboratory of Bioinorganic Chemistry and Materia Medica, Hubei Engineering Research Center for Biomaterials and Medical Protective Materials, School of Chemistry and Chemical Engineering, Huazhong University of Science and TechnologyHubei Key Laboratory of Bioinorganic Chemistry and Materia Medica, Hubei Engineering Research Center for Biomaterials and Medical Protective Materials, School of Chemistry and Chemical Engineering, Huazhong University of Science and TechnologyHubei Key Laboratory of Bioinorganic Chemistry and Materia Medica, Hubei Engineering Research Center for Biomaterials and Medical Protective Materials, School of Chemistry and Chemical Engineering, Huazhong University of Science and TechnologyHubei Key Laboratory of Bioinorganic Chemistry and Materia Medica, Hubei Engineering Research Center for Biomaterials and Medical Protective Materials, School of Chemistry and Chemical Engineering, Huazhong University of Science and TechnologyNational Engineering Research Center for NanomedicineHubei Key Laboratory of Bioinorganic Chemistry and Materia Medica, Hubei Engineering Research Center for Biomaterials and Medical Protective Materials, School of Chemistry and Chemical Engineering, Huazhong University of Science and TechnologyAbstract Anaerobic bacteria-mediated tumor therapy faces multiple challenges, including potential toxic side effects, complex manufacturing processes, and impaired hypoxic targeting. Here, based on the excellent biocompatibility and distinctive metabolic ability of natural anaerobic sulfate-reducing bacteria (SRB) to dissimilate sulfate into sulfide, we construct in situ-biosynthesized ferrous sulfide nanoparticle-SRB (FeS@SRB) biohybrid to enhance tumor-targeted therapy. Interestingly, SRB acts as both a biosynthesis factory and active tumor-targeted delivery vehicles. Our systematic studies reveal that FeS@SRB has excellent biosafety and tumor targeting capabilities, achieving over 50% tumor delivery efficiency in female mice post-intravenous injection, which is 17 times higher than that of conventional chemically-synthesized FeS@BSA nanoparticles. Upon near-infrared laser irradiation, FeS@SRB hybrids exhibit synergistic photothermal-chemodynamic effect, amplifying oxidative stress to trigger tumor cells ferroptosis and apoptosis, thereby effectively suppressing both subcutaneous and orthotopic tumor growth. This SRB-based therapeutic strategy expands research into tumor-targeting platforms and the biosynthesis of metal sulfide nanoparticles for enhanced tumor therapy.https://doi.org/10.1038/s41467-025-61675-4 |
| spellingShingle | Mengna Dong Xinhui Yang Wenqian Zhang Yuzhi Qiu Peng Song Hongfang Liu Yajiang Yang Xiangliang Yang Qin Wang Living therapeutics of nonpathogenic bacteria as biosynthesis factory and active carriers for enhancing tumor-targeted therapy Nature Communications |
| title | Living therapeutics of nonpathogenic bacteria as biosynthesis factory and active carriers for enhancing tumor-targeted therapy |
| title_full | Living therapeutics of nonpathogenic bacteria as biosynthesis factory and active carriers for enhancing tumor-targeted therapy |
| title_fullStr | Living therapeutics of nonpathogenic bacteria as biosynthesis factory and active carriers for enhancing tumor-targeted therapy |
| title_full_unstemmed | Living therapeutics of nonpathogenic bacteria as biosynthesis factory and active carriers for enhancing tumor-targeted therapy |
| title_short | Living therapeutics of nonpathogenic bacteria as biosynthesis factory and active carriers for enhancing tumor-targeted therapy |
| title_sort | living therapeutics of nonpathogenic bacteria as biosynthesis factory and active carriers for enhancing tumor targeted therapy |
| url | https://doi.org/10.1038/s41467-025-61675-4 |
| work_keys_str_mv | AT mengnadong livingtherapeuticsofnonpathogenicbacteriaasbiosynthesisfactoryandactivecarriersforenhancingtumortargetedtherapy AT xinhuiyang livingtherapeuticsofnonpathogenicbacteriaasbiosynthesisfactoryandactivecarriersforenhancingtumortargetedtherapy AT wenqianzhang livingtherapeuticsofnonpathogenicbacteriaasbiosynthesisfactoryandactivecarriersforenhancingtumortargetedtherapy AT yuzhiqiu livingtherapeuticsofnonpathogenicbacteriaasbiosynthesisfactoryandactivecarriersforenhancingtumortargetedtherapy AT pengsong livingtherapeuticsofnonpathogenicbacteriaasbiosynthesisfactoryandactivecarriersforenhancingtumortargetedtherapy AT hongfangliu livingtherapeuticsofnonpathogenicbacteriaasbiosynthesisfactoryandactivecarriersforenhancingtumortargetedtherapy AT yajiangyang livingtherapeuticsofnonpathogenicbacteriaasbiosynthesisfactoryandactivecarriersforenhancingtumortargetedtherapy AT xiangliangyang livingtherapeuticsofnonpathogenicbacteriaasbiosynthesisfactoryandactivecarriersforenhancingtumortargetedtherapy AT qinwang livingtherapeuticsofnonpathogenicbacteriaasbiosynthesisfactoryandactivecarriersforenhancingtumortargetedtherapy |